or

Crude Oil WTI Feb '18 (CLG18)

63.49s +0.12 (+0.19%) 01/22/18 [NYMEX]
N/A x N/A N/A x N/A
underlying price ()
Quote Overview for Mon, Jan 22nd, 2018
Day Low
63.17
Day High
64.14
Open 63.61
Previous Close 63.37 63.37
Volume 29,710 29,710
Open Interest 33,579 33,579
Stochastic %K 74.51% 74.51%
Weighted Alpha +24.48 +24.48
5-Day Change -0.81 (-1.26%) -0.81 (-1.26%)
52-Week Range 43.76 - 64.89 43.76 - 64.89
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure

Crude Oil WTI Futures Market News and Commentary

Dollar Weakness and Stock Gains Lift Crude Prices

June WTI crude oil (CLM25) Thursday closed up +0.52 (+0.84%), and June RBOB gasoline (RBM25) closed up +0.0220 (+1.06%).

Crude oil and gasoline prices on Thursday posted moderate gains.  Thursday's weaker dollar supported energy prices.  Also, Thursday's stock strength shows confidence in the economic outlook supporting energy demand.   Gains in crude were limited on concern the China-US trade war will drag on and undercut economic growth and energy demand after Treasury Secretary Bessent said President Trump hasn't offered to take down US tariffs on China on a unilateral basis.

Fears about the oversupply of crude are bearish for prices after Reuters reported Wednesday that several OPEC+ members would suggest accelerating oil output hikes in June for a second consecutive month.   Also, Kazakhstan's energy minister said it wouldn't cut its crude production levels and will prioritize national interests over those of OPEC+ when deciding on oil production levels, which risks... Read more

Contract Specifications

See More
Contract
Crude Oil West Texas Intermediate
Contract Size
1,000 U.S. barrels (42,000 gallons)
Tick Size
1 cent per barrel ($10.00 per contract)
Trading Hours
5:00p.m. - 4:00p.m. (Sun-Fri) (RTH 8:00a.m. - 1:30p.m.) (Settles 1:30p.m.) CST
Exchange
NYMEX
Point Value
$1,000
Margin/Maintenance
$6,618/6,017
First Notice Date
01/24/18
Expiration Date
01/22/18 (expired)

Seasonal Chart

Crude Oil WTI Feb '18
Average Price Chart for 5 Prior Feb Contracts

Commitment of Traders Positions as of Apr 15, 2025

View Chart Details
Commercials - Long / Short
766,976 (-43,235)
920,691 (-38,079)
Non-Commercials - Long / Short
311,402 (-5,886)
165,032 (-12,661)
Producers - Long / Short
636,108 (-40,805)
343,321 (-35,467)
Swap Dealers - Long / Short
34,738 (-2,416)
481,240 (-2,598)
Managed Money - Long / Short
179,562 (+23,895)
99,649 (-7,479)
Other Reportables - Long / Short
131,840 (-29,781)
65,383 (-5,182)
Get Realtime - Quotes and Charts for Futures Traders. Learn More >>

Price Performance

See More
Period Period Low Period High Performance
1-Month
58.32 +8.86%
on 12/26/17
Period Open: 58.47
64.89 -2.16%
on 01/16/18
+5.02 (+8.59%)
since 12/22/17
3-Month
51.85 +22.45%
on 10/24/17
Period Open: 52.17
64.89 -2.16%
on 01/16/18
+11.32 (+21.70%)
since 10/20/17
52-Week
43.76 +45.09%
on 06/21/17
Period Open: 56.11
64.89 -2.16%
on 01/16/18
+7.38 (+13.15%)
since 01/20/17

More Crude Oil WTI Quotes

All Futures Prices
Please wait...
Please wait...
false

Most Recent Stories

More News
OPEC Rumors of a June Output Increase, Ceilings Hold for Brent and WTI

The June WTI (CLM25 ) contract settled at 62.79 (+0.52) [+0.84%] , high of 63.31, low of 61.99. Spot price is 62.24 (-1.44). Open interest for CLM25 is 300,434. CLM25 settled below its 5 day (63.02), below...

CLM25 : 62.83 (+0.06%)
QAM25 : 66.57 (+0.03%)
Dollar Weakness and Stock Gains Lift Crude Prices

June WTI crude oil (CLM25 ) Thursday closed up +0.52 (+0.84%), and June RBOB gasoline (RBM25 ) closed up +0.0220 (+1.06%). Crude oil and gasoline prices on Thursday posted moderate gains. Thursday's weaker...

CLM25 : 62.83 (+0.06%)
RBM25 : 2.1017 (+0.26%)
Nat-Gas Prices Tumble as Weekly EIA Inventories Jump

May Nymex natural gas (NGK25 ) on Thursday closed down by -0.092 (-3.04%). May nat-gas prices on Thursday tumbled to a 5-month nearest-futures low and settled sharply lower on a larger-than-expected build...

NGM25 : 3.101 (+0.13%)
This Under-the-Radar Energy Stock Is Heating Up

Atmos Energy Corporation (ATO) is a regulated natural gas distributor with a strong focus on modernizing its network and reducing regulatory lag. ATO has a 100% technical “buy” signal and is trading...

LNG : 232.27 (+1.83%)
RSG : 240.76 (-0.25%)
ATO : 159.67 (+0.05%)
Crude Moderately Higher on Dollar Weakness and Stock Gains

June WTI crude oil (CLM25 ) today is up +0.21 (+0.34%), and June RBOB gasoline (RBM25) is up +0.0069 (+0.33%). Crude oil and gasoline prices today are moderately higher. Today's weaker dollar (DXY00 )...

CLM25 : 62.83 (+0.06%)
DXY00 : 99.377s (-0.47%)
WTI Futures Rebound Off Support as OPEC Response Looms

WTI Crude Oil futures fell yesterday on trade relations and news regarding OPEC. Kazakhstan came out yesterday and said that their oil production was out of their control, dashing hopes they would be willing...

Marathon Petroleum's Quarterly Earnings Preview: What You Need to Know

Marathon Petroleum is expected to release its fiscal first-quarter earnings next month, and analysts project a triple-digit earnings fall.

XLE : 82.54 (+1.60%)
MPC : 137.54 (+2.41%)
$SPX : 5,484.77 (+2.03%)
Crude Prices Fall on Fears of Global Oversupply

June WTI crude oil (CLM25 ) Wednesday closed down -1.40 (-2.20%), and June RBOB gasoline (RBM25 ) closed down -0.0165 (-0.79%). Crude oil and gasoline prices on Wednesday fell back from 2-1/2 week highs...

CLM25 : 62.83 (+0.06%)
RBM25 : 2.1017 (+0.26%)
Forecasts for Cooler US Temps Boost Nat-Gas Prices

May Nymex natural gas (NGK25 ) on Wednesday closed up by +0.015 (+0.50%). May nat-gas prices posted moderate gains on Wednesday as forecasts for cooler US temperatures sparked some short-covering in nat-gas...

NGM25 : 3.101 (+0.13%)
Crude hits rare resistance—Kazakhstan rattles OPEC+ expectations.

WTI Crude Oil futures rallied yesterday after Scott Bessent’s positive comments regarding trade relations with China and President Trump’s more hawkish Iran comments.

Generation Bio Reports Business Highlights and Third Quarter 2021 Financial Results

New preclinical retinal data illustrating potential for expansive therapeutic applications of ctLNP delivery presented at ESGCT 2021 Annual Virtual...

GBIO : 0.4206 (-6.62%)
Generation Bio Presents Data Demonstrating First Lipid Nanoparticle to Achieve Uniform Retinal Transduction and Tolerability via Sub-Retinal Delivery of ceDNA and mRNA at the European Society of Gene and Cell Therapy 2021 Annual Virtual Congress

Sub-retinal delivery of closed-ended DNA (ceDNA) using a retina-specific cell-targeted LNP (ctLNP) demonstrated broad photoreceptor distribution, durable...

GBIO : 0.4206 (-6.62%)
Generation Bio to Present at Jefferies Virtual Gene Therapy/Editing Summit

CAMBRIDGE, Mass., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people...

GBIO : 0.4206 (-6.62%)
Generation Bio to Present at European Society of Gene and Cell Therapy 2021 Annual Virtual Congress

CAMBRIDGE, Mass., Oct. 15, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people...

GBIO : 0.4206 (-6.62%)
Generation Bio Reports Business Highlights and Second Quarter 2021 Financial Results

CAMBRIDGE, Mass., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co . (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, reported...

GBIO : 0.4206 (-6.62%)
Generation Bio to Present at Wedbush PacGrow Healthcare Conference 2021

CAMBRIDGE, Mass., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced...

GBIO : 0.4206 (-6.62%)
Generation Bio Announces Plan to Scale Next-Generation Rapid Enzymatic Manufacturing Process Across Portfolio and Provides Pipeline Update

Company to transition all portfolio programs to rapid enzymatic synthesis (RES), enabling improved quality, scale and speed of closed-ended DNA manufacturing

GBIO : 0.4206 (-6.62%)
Generation Bio to Present at William Blair Biotech Focus Conference

CAMBRIDGE, Mass., July 08, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, announced today that Geoff...

GBIO : 0.4206 (-6.62%)
Generation Bio to Present at the JMP Securities Life Sciences Conference

CAMBRIDGE, Mass., June 09, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, announced today that Geoff...

GBIO : 0.4206 (-6.62%)
Generation Bio to Present at the Jefferies Virtual Healthcare Conference

CAMBRIDGE, Mass., May 27, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, announced today that Geoff...

GBIO : 0.4206 (-6.62%)
Generation Bio Reports Business Highlights and Third Quarter 2021 Financial Results

New preclinical retinal data illustrating potential for expansive therapeutic applications of ctLNP delivery presented at ESGCT 2021 Annual Virtual...

GBIO : 0.4206 (-6.62%)
Generation Bio Presents Data Demonstrating First Lipid Nanoparticle to Achieve Uniform Retinal Transduction and Tolerability via Sub-Retinal Delivery of ceDNA and mRNA at the European Society of Gene and Cell Therapy 2021 Annual Virtual Congress

Sub-retinal delivery of closed-ended DNA (ceDNA) using a retina-specific cell-targeted LNP (ctLNP) demonstrated broad photoreceptor distribution, durable...

GBIO : 0.4206 (-6.62%)
Generation Bio to Present at Jefferies Virtual Gene Therapy/Editing Summit

CAMBRIDGE, Mass., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people...

GBIO : 0.4206 (-6.62%)
Generation Bio to Present at European Society of Gene and Cell Therapy 2021 Annual Virtual Congress

CAMBRIDGE, Mass., Oct. 15, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people...

GBIO : 0.4206 (-6.62%)
Generation Bio Reports Business Highlights and Second Quarter 2021 Financial Results

CAMBRIDGE, Mass., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co . (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, reported...

GBIO : 0.4206 (-6.62%)
Generation Bio to Present at Wedbush PacGrow Healthcare Conference 2021

CAMBRIDGE, Mass., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced...

GBIO : 0.4206 (-6.62%)
Generation Bio Announces Plan to Scale Next-Generation Rapid Enzymatic Manufacturing Process Across Portfolio and Provides Pipeline Update

Company to transition all portfolio programs to rapid enzymatic synthesis (RES), enabling improved quality, scale and speed of closed-ended DNA manufacturing

GBIO : 0.4206 (-6.62%)
Generation Bio to Present at William Blair Biotech Focus Conference

CAMBRIDGE, Mass., July 08, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, announced today that Geoff...

GBIO : 0.4206 (-6.62%)
Generation Bio to Present at the JMP Securities Life Sciences Conference

CAMBRIDGE, Mass., June 09, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, announced today that Geoff...

GBIO : 0.4206 (-6.62%)
Generation Bio to Present at the Jefferies Virtual Healthcare Conference

CAMBRIDGE, Mass., May 27, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, announced today that Geoff...

GBIO : 0.4206 (-6.62%)
Generation Bio Reports Business Highlights and Third Quarter 2021 Financial Results

New preclinical retinal data illustrating potential for expansive therapeutic applications of ctLNP delivery presented at ESGCT 2021 Annual Virtual...

GBIO : 0.4206 (-6.62%)
Generation Bio Presents Data Demonstrating First Lipid Nanoparticle to Achieve Uniform Retinal Transduction and Tolerability via Sub-Retinal Delivery of ceDNA and mRNA at the European Society of Gene and Cell Therapy 2021 Annual Virtual Congress

Sub-retinal delivery of closed-ended DNA (ceDNA) using a retina-specific cell-targeted LNP (ctLNP) demonstrated broad photoreceptor distribution, durable...

GBIO : 0.4206 (-6.62%)
Generation Bio to Present at Jefferies Virtual Gene Therapy/Editing Summit

CAMBRIDGE, Mass., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people...

GBIO : 0.4206 (-6.62%)
Generation Bio to Present at European Society of Gene and Cell Therapy 2021 Annual Virtual Congress

CAMBRIDGE, Mass., Oct. 15, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people...

GBIO : 0.4206 (-6.62%)
Generation Bio Reports Business Highlights and Second Quarter 2021 Financial Results

CAMBRIDGE, Mass., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co . (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, reported...

GBIO : 0.4206 (-6.62%)
Generation Bio to Present at Wedbush PacGrow Healthcare Conference 2021

CAMBRIDGE, Mass., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced...

GBIO : 0.4206 (-6.62%)
Generation Bio Announces Plan to Scale Next-Generation Rapid Enzymatic Manufacturing Process Across Portfolio and Provides Pipeline Update

Company to transition all portfolio programs to rapid enzymatic synthesis (RES), enabling improved quality, scale and speed of closed-ended DNA manufacturing

GBIO : 0.4206 (-6.62%)
Generation Bio to Present at William Blair Biotech Focus Conference

CAMBRIDGE, Mass., July 08, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, announced today that Geoff...

GBIO : 0.4206 (-6.62%)
Generation Bio to Present at the JMP Securities Life Sciences Conference

CAMBRIDGE, Mass., June 09, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, announced today that Geoff...

GBIO : 0.4206 (-6.62%)
Generation Bio to Present at the Jefferies Virtual Healthcare Conference

CAMBRIDGE, Mass., May 27, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, announced today that Geoff...

GBIO : 0.4206 (-6.62%)

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 64.57
1st Resistance Point 64.03
Last Price 63.49s
1st Support Level 63.06
2nd Support Level 62.63
3rd Support Level N/A

See More

52-Week High 64.89
Last Price 63.49s
Fibonacci 61.8% 56.82
Fibonacci 50% 54.32
Fibonacci 38.2% 51.83
52-Week Low 43.76

See More

Solutions for Energy Professionals barchart.com/cmdty
Energy Data and Statistics
Explore Data
cmdtyView Pro for Commodity Professionals
Start Free Trial
We help Energy Professionals make better decisions
Learn Now
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective

Info When You Need It Most.

Barchart Premier is one of the most powerful tools in the investment world. Come see why so many subscribers love it — and try it risk-free for 30 days.